. 2024 Sep 25;19(9):e0311084. doi: 10.1371/journal.pone.0311084

Table 1. Patient characteristics.

Characteristic	All patients
N	110
Age	72 (66–78)
Sex (male/female)	90/20
PS (0/1/2)	92/16/2
Body Mass Index (kg/m ² )	23.4 (20.9–26.2)
Cause of HCC (HBV/HCV/Non-B, C)	21/42/47
Child-Pugh class A/B	100/10
BCLC stage (0/A/B/C)	1/1/61/47
Macrovascular invasion (Yes/No)	19/91
Extrahepatic spread (Yes/no)	36/84
AFP [ng/mL]	54.6 (4.0–972.3)
DCP [mAU/mL]	1360 (151.2–9656.5) ^*
Combination therapy (Yes/No)	9/101^†
Treatment line First/Later-line	40/70
Follow up duration	5.9 (4.2–7.5)

* 5 cases blank

^† All combination therapies were performed after best-response assessment median (interquartile range)